Facial Injectable Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Description

Facial Injectable refers to skin fillers used for a variety of applications, including dark circle removal, eyebrow uplifting, lip thinning, cheekbone enhancement, wrinkle reduction, acne treatment, scar treatment, and more. It plays a crucial role in rejuvenating and resurfacing the skin. There are two primary types of facial injectables: botulinum toxin and dermal fillers. Dermal fillers may include hyaluronic acid-based, calcium hydroxyapatite-based, poly-lactic acid-based, collagen-based, or polymethylmethacrylate-based (non-absorbable) products.

The global Facial Injectable market is witnessing substantial growth, driven by leading manufacturers such as Allergen, Merz Pharma, and Nestle skin health. These industry giants are actively focusing on new product launches in the dermal fillers and botulinum toxin products category. Innovations in product design and collaborative efforts are also shaping the market landscape.

Leading Players and Collaborative Efforts

Prominent companies like Allergen, Merz Pharma, and Nestle skin health are at the forefront of the Facial Injectable market. These industry leaders are intensifying their efforts in new product development and design innovations. Collaboration has become a key strategy for market expansion, with a particular focus on building distributor relationships in emerging markets across Asia and Latin America.

Rising Male Population's Interest in Aesthetic Procedures

A notable trend in the market is the increasing number of male patients opting for aesthetic procedures, including lip augmentation, acne treatment, facelifts, scar treatment, and other facial aesthetic procedures. These procedures often require the use of facial injectables. The demand for facial injectables is expected to surge as more individuals, including males, seek these aesthetic enhancements.

Versatile Applications of Facial Injectable

Facial injectables are gaining popularity for various applications such as reducing skin folds, smoothing the skin, enhancing lips, removing wrinkles, treating acne, and addressing scars. Research is underway to explore additional applications, including the treatment of paralyzed vocal cords, which, if approved by the US FDA, could further fuel market growth. Facial injectables play a vital role in skin rejuvenation and resurfacing.

Engagement of Physicians and End Users

Many companies are actively engaging with physicians to expand their product reach among end users. This strategy not only strengthens their market presence but also mitigates the threat posed by new entrants. Regional physician learning programs are being initiated to increase product awareness among end users. Additionally, direct interactions and engagement with patients help monitor and minimize adverse effects associated with excessive use of dermal fillers or botulinum toxins.

Market Expansion through Partnerships

Growing demand for facial injectables, government support for product approvals in new application areas, and the commercialization of novel solutions have led to increased partnerships, collaborations, mergers, and agreements among facial injectable manufacturers. These companies are actively seeking to expand their presence in the Asian market due to the rise of cosmetic tourism in the region. Distribution agreements are being adopted as a strategic expansion tactic, and some manufacturers are collaborating with other aesthetic companies beyond facial injectables to capture new markets and gain a competitive edge.

Increasing Number of Authorized Aesthetic Surgeons

The expanding network of plastic surgeons is driving the demand for aesthetic procedures, subsequently boosting the demand for facial injectables. Furthermore, FDA approvals now allow other physicians, such as dentists, to perform facial injectable procedures, especially after dental treatments that may require facial adjustments. This development is expected to further bolster the growth of the facial injectable market.

Competitive Analysis

The competition within the facial injectable market is led by key players like Nestle skin health, Sinclair pharma, Zimmer Biomet, Allergan, Anika therapeutics Inc., Merz Pharma, Ipsen, Teoxane laboratories, Prollelium Medical Technologies Inc., Suneva Medical Inc., and others. These companies offer a wide range of products, including various dermal fillers. They are dedicated to developing high-quality products and expanding their presence in emerging markets, while also maintaining strong distributor relationships.

Facial Injectable Market Segmentation

The report provides a detailed taxonomy of the facial Injectable market, categorizing it based on product type, applications, end users, and region. The two primary types of facial Injectable utilized in the market are dermal fillers and botulinum toxin.

Dermal fillers are administered with small gauge injectors into the deep dermal area to fill spaces and stimulate collagen production in the body. They can be categorized as Hyaluronic acid-based, Calcium Hydroxyapatite-based, Poly-Lactic acid-based, collagen-based, or Polymethylmethacrylate-based (non-absorbable). Botulinum toxin, on the other hand, is initially a single chain molecule of about 150KD, which undergoes cleavage to form a dichain molecule with a disulphide bridge. Popular brands of botulinum toxin include Dysport, Xeomin, Meditoxin, Botulax, and Nabota.

Facial Injectable applications encompass aesthetic restoration, dentistry, and reconstructive surgery, with aesthetic restoration anticipated to hold a significant share in the market. End-use segments in the facial Injectable market comprise hospitals, specialty clinics, and beauty clinics.

The facial Injectable market has been analyzed across regions including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa.

1. Executive Summary

1.1. Global Facial Injectable Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global Facial Injectable Market Outlook, 2018 - 2031

3.1. Global Facial Injectable Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
- 3.1.1. Key Highlights
  - 3.1.1.1. Botulinum Toxin
    - 3.1.1.1.1. Toxin A
    - 3.1.1.1.2. Toxin B
  - 3.1.1.2. Dermal Fillers
    - 3.1.1.2.1. Hyaluronic Acid
    - 3.1.1.2.2. Poly-L-Lactic Acid
    - 3.1.1.2.3. Calcium Hydroxyapatite
    - 3.1.1.2.4. Poly Methyl methacrylate
3.2. Global Facial Injectable Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 3.2.1. Key Highlights
  - 3.2.1.1. Aesthetic Restoration
  - 3.2.1.2. Dentistry
  - 3.2.1.3. Reconstructive Surgery
3.3. Global Facial Injectable Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 3.3.1. Key Highlights
  - 3.3.1.1. Hospitals
  - 3.3.1.2. Specialty Clinics
  - 3.3.1.3. Spa & Beauty Clinic
3.4. Global Facial Injectable Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
- 3.4.1. Key Highlights
  - 3.4.1.1. North America
  - 3.4.1.2. Europe
  - 3.4.1.3. Asia Pacific
  - 3.4.1.4. Latin America
  - 3.4.1.5. Middle East & Africa

4. North America Facial Injectable Market Outlook, 2018 - 2031

4.1. North America Facial Injectable Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
- 4.1.1. Key Highlights
  - 4.1.1.1. Botulinum Toxin
    - 4.1.1.1.1. Toxin A
    - 4.1.1.1.2. Toxin B
  - 4.1.1.2. Dermal Fillers
    - 4.1.1.2.1. Hyaluronic Acid
    - 4.1.1.2.2. Poly-L-Lactic Acid
    - 4.1.1.2.3. Calcium Hydroxyapatite
    - 4.1.1.2.4. Poly Methyl methacrylate
4.2. North America Facial Injectable Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 4.2.1. Key Highlights
  - 4.2.1.1. Aesthetic Restoration
  - 4.2.1.2. Dentistry
  - 4.2.1.3. Reconstructive Surgery
4.3. North America Facial Injectable Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 4.3.1. Key Highlights
  - 4.3.1.1. Hospitals
  - 4.3.1.2. Specialty Clinics
  - 4.3.1.3. Spa & Beauty Clinic
4.4. North America Facial Injectable Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 4.4.1. Key Highlights
  - 4.4.1.1. U.S. Facial Injectable Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 4.4.1.2. U.S. Facial Injectable Market by Application, Value (US$ Bn), 2018 - 2031
  - 4.4.1.3. U.S. Facial Injectable Market End User, Value (US$ Bn), 2018 - 2031
  - 4.4.1.4. Canada Facial Injectable Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 4.4.1.5. Canada Facial Injectable Market by Application, Value (US$ Bn), 2018 - 2031
  - 4.4.1.6. Canada Facial Injectable Market End User, Value (US$ Bn), 2018 - 2031
- 4.4.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Facial Injectable Market Outlook, 2018 - 2031

5.1. Europe Facial Injectable Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
- 5.1.1. Key Highlights
  - 5.1.1.1. Botulinum Toxin
    - 5.1.1.1.1. Toxin A
    - 5.1.1.1.2. Toxin B
  - 5.1.1.2. Dermal Fillers
    - 5.1.1.2.1. Hyaluronic Acid
    - 5.1.1.2.2. Poly-L-Lactic Acid
    - 5.1.1.2.3. Calcium Hydroxyapatite
    - 5.1.1.2.4. Poly Methyl methacrylate
5.2. Europe Facial Injectable Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 5.2.1. Key Highlights
  - 5.2.1.1. Aesthetic Restoration
  - 5.2.1.2. Dentistry
  - 5.2.1.3. Reconstructive Surgery
5.3. Europe Facial Injectable Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 5.3.1. Key Highlights
  - 5.3.1.1. Hospitals
  - 5.3.1.2. Specialty Clinics
  - 5.3.1.3. Spa & Beauty Clinic
5.4. Europe Facial Injectable Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 5.4.1. Key Highlights
  - 5.4.1.1. Germany Facial Injectable Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 5.4.1.2. Germany Facial Injectable Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.4.1.3. Germany Facial Injectable Market End User, Value (US$ Bn), 2018 - 2031
  - 5.4.1.4. U.K. Facial Injectable Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 5.4.1.5. U.K. Facial Injectable Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.4.1.6. U.K. Facial Injectable Market End User, Value (US$ Bn), 2018 - 2031
  - 5.4.1.7. France Facial Injectable Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 5.4.1.8. France Facial Injectable Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.4.1.9. France Facial Injectable Market End User, Value (US$ Bn), 2018 - 2031
  - 5.4.1.10. Italy Facial Injectable Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 5.4.1.11. Italy Facial Injectable Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.4.1.12. Italy Facial Injectable Market End User, Value (US$ Bn), 2018 - 2031
  - 5.4.1.13. Turkey Facial Injectable Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 5.4.1.14. Turkey Facial Injectable Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.4.1.15. Turkey Facial Injectable Market End User, Value (US$ Bn), 2018 - 2031
  - 5.4.1.16. Russia Facial Injectable Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 5.4.1.17. Russia Facial Injectable Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.4.1.18. Russia Facial Injectable Market End User, Value (US$ Bn), 2018 - 2031
  - 5.4.1.19. Rest of Europe Facial Injectable Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 5.4.1.20. Rest of Europe Facial Injectable Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.4.1.21. Rest of Europe Facial Injectable Market End User, Value (US$ Bn), 2018 - 2031
- 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Facial Injectable Market Outlook, 2018 - 2031

6.1. Asia Pacific Facial Injectable Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
- 6.1.1. Key Highlights
  - 6.1.1.1. Botulinum Toxin
    - 6.1.1.1.1. Toxin A
    - 6.1.1.1.2. Toxin B
  - 6.1.1.2. Dermal Fillers
    - 6.1.1.2.1. Hyaluronic Acid
    - 6.1.1.2.2. Poly-L-Lactic Acid
    - 6.1.1.2.3. Calcium Hydroxyapatite
    - 6.1.1.2.4. Poly Methyl methacrylate
6.2. Asia Pacific Facial Injectable Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 6.2.1. Key Highlights
  - 6.2.1.1. Aesthetic Restoration
  - 6.2.1.2. Dentistry
  - 6.2.1.3. Reconstructive Surgery
6.3. Asia Pacific Facial Injectable Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 6.3.1. Key Highlights
  - 6.3.1.1. Hospitals
  - 6.3.1.2. Specialty Clinics
  - 6.3.1.3. Spa & Beauty Clinic
6.4. Asia Pacific Facial Injectable Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 6.4.1. Key Highlights
  - 6.4.1.1. China Facial Injectable Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 6.4.1.2. China Facial Injectable Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.4.1.3. China Facial Injectable Market End User, Value (US$ Bn), 2018 - 2031
  - 6.4.1.4. Japan Facial Injectable Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 6.4.1.5. Japan Facial Injectable Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.4.1.6. Japan Facial Injectable Market End User, Value (US$ Bn), 2018 - 2031
  - 6.4.1.7. South Korea Facial Injectable Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 6.4.1.8. South Korea Facial Injectable Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.4.1.9. South Korea Facial Injectable Market End User, Value (US$ Bn), 2018 - 2031
  - 6.4.1.10. India Facial Injectable Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 6.4.1.11. India Facial Injectable Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.4.1.12. India Facial Injectable Market End User, Value (US$ Bn), 2018 - 2031
  - 6.4.1.13. Southeast Asia Facial Injectable Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 6.4.1.14. Southeast Asia Facial Injectable Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.4.1.15. Southeast Asia Facial Injectable Market End User, Value (US$ Bn), 2018 - 2031
  - 6.4.1.16. Rest of Asia Pacific Facial Injectable Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 6.4.1.17. Rest of Asia Pacific Facial Injectable Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.4.1.18. Rest of Asia Pacific Facial Injectable Market End User, Value (US$ Bn), 2018 - 2031
- 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Facial Injectable Market Outlook, 2018 - 2031

7.1. Latin America Facial Injectable Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
- 7.1.1. Key Highlights
  - 7.1.1.1. Botulinum Toxin
    - 7.1.1.1.1. Toxin A
    - 7.1.1.1.2. Toxin B
  - 7.1.1.2. Dermal Fillers
    - 7.1.1.2.1. Hyaluronic Acid
    - 7.1.1.2.2. Poly-L-Lactic Acid
    - 7.1.1.2.3. Calcium Hydroxyapatite
    - 7.1.1.2.4. Poly Methyl methacrylate
7.2. Latin America Facial Injectable Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 7.2.1. Key Highlights
  - 7.2.1.1. Aesthetic Restoration
  - 7.2.1.2. Dentistry
  - 7.2.1.3. Reconstructive Surgery
7.3. Latin America Facial Injectable Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Hospitals
  - 7.3.1.2. Specialty Clinics
  - 7.3.1.3. Spa & Beauty Clinic
7.4. Latin America Facial Injectable Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 7.4.1. Key Highlights
  - 7.4.1.1. Brazil Facial Injectable Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 7.4.1.2. Brazil Facial Injectable Market by Application, Value (US$ Bn), 2018 - 2031
  - 7.4.1.3. Brazil Facial Injectable Market End User, Value (US$ Bn), 2018 - 2031
  - 7.4.1.4. Mexico Facial Injectable Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 7.4.1.5. Mexico Facial Injectable Market by Application, Value (US$ Bn), 2018 - 2031
  - 7.4.1.6. Mexico Facial Injectable Market End User, Value (US$ Bn), 2018 - 2031
  - 7.4.1.7. Argentina Facial Injectable Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 7.4.1.8. Argentina Facial Injectable Market by Application, Value (US$ Bn), 2018 - 2031
  - 7.4.1.9. Argentina Facial Injectable Market End User, Value (US$ Bn), 2018 - 2031
  - 7.4.1.10. Rest of Latin America Facial Injectable Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 7.4.1.11. Rest of Latin America Facial Injectable Market by Application, Value (US$ Bn), 2018 - 2031
  - 7.4.1.12. Rest of Latin America Facial Injectable Market End User, Value (US$ Bn), 2018 - 2031
- 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Facial Injectable Market Outlook, 2018 - 2031

8.1. Middle East & Africa Facial Injectable Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
- 8.1.1. Key Highlights
  - 8.1.1.1. Botulinum Toxin
    - 8.1.1.1.1. Toxin A
    - 8.1.1.1.2. Toxin B
  - 8.1.1.2. Dermal Fillers
    - 8.1.1.2.1. Hyaluronic Acid
    - 8.1.1.2.2. Poly-L-Lactic Acid
    - 8.1.1.2.3. Calcium Hydroxyapatite
    - 8.1.1.2.4. Poly Methyl methacrylate
8.2. Middle East & Africa Facial Injectable Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 8.2.1. Key Highlights
  - 8.2.1.1. Aesthetic Restoration
  - 8.2.1.2. Dentistry
  - 8.2.1.3. Reconstructive Surgery
8.3. Middle East & Africa Facial Injectable Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 8.3.1. Key Highlights
  - 8.3.1.1. Hospitals
  - 8.3.1.2. Specialty Clinics
  - 8.3.1.3. Spa & Beauty Clinic
8.4. Middle East & Africa Facial Injectable Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 8.4.1. Key Highlights
  - 8.4.1.1. GCC Facial Injectable Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 8.4.1.2. GCC Facial Injectable Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.4.1.3. GCC Facial Injectable Market End User, Value (US$ Bn), 2018 - 2031
  - 8.4.1.4. South Africa Facial Injectable Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 8.4.1.5. South Africa Facial Injectable Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.4.1.6. South Africa Facial Injectable Market End User, Value (US$ Bn), 2018 - 2031
  - 8.4.1.7. Egypt Facial Injectable Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 8.4.1.8. Egypt Facial Injectable Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.4.1.9. Egypt Facial Injectable Market End User, Value (US$ Bn), 2018 - 2031
  - 8.4.1.10. Nigeria Facial Injectable Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 8.4.1.11. Nigeria Facial Injectable Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.4.1.12. Nigeria Facial Injectable Market End User, Value (US$ Bn), 2018 - 2031
  - 8.4.1.13. Rest of Middle East & Africa Facial Injectable Market by Product Type, Value (US$ Bn), 2018 - 2031
  - 8.4.1.14. Rest of Middle East & Africa Facial Injectable Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.4.1.15. Rest of Middle East & Africa Facial Injectable Market End User, Value (US$ Bn), 2018 - 2031
- 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. Product Type vs End User Heatmap
9.2. Manufacturer vs End User Heatmap
9.3. Company Market Share Analysis, 2023
9.4. Competitive Dashboard
9.5. Company Profiles
- 9.5.1. Nestle Skin Health
  - 9.5.1.1. Company Overview
  - 9.5.1.2. Product Type Portfolio
  - 9.5.1.3. Financial Overview
  - 9.5.1.4. Business Strategies and Development
- 9.5.2. Sinclair Pharma
  - 9.5.2.1. Company Overview
  - 9.5.2.2. Product Type Portfolio
  - 9.5.2.3. Financial Overview
  - 9.5.2.4. Business Strategies and Development
- 9.5.3. Zimmer Biomet
  - 9.5.3.1. Company Overview
  - 9.5.3.2. Product Type Portfolio
  - 9.5.3.3. Financial Overview
  - 9.5.3.4. Business Strategies and Development
- 9.5.4. Anika Therapeutics, Inc.
  - 9.5.4.1. Company Overview
  - 9.5.4.2. Product Type Portfolio
  - 9.5.4.3. Financial Overview
  - 9.5.4.4. Business Strategies and Development
- 9.5.5. Merz Pharma
  - 9.5.5.1. Company Overview
  - 9.5.5.2. Product Type Portfolio
  - 9.5.5.3. Financial Overview
  - 9.5.5.4. Business Strategies and Development
- 9.5.6. Ipsen Pharma
  - 9.5.6.1. Company Overview
  - 9.5.6.2. Product Type Portfolio
  - 9.5.6.3. Financial Overview
  - 9.5.6.4. Business Strategies and Development
- 9.5.7. Teoxane Laboratories
  - 9.5.7.1. Company Overview
  - 9.5.7.2. Product Type Portfolio
  - 9.5.7.3. Financial Overview
  - 9.5.7.4. Business Strategies and Development
- 9.5.8. Prollenium Medical Technologies
  - 9.5.8.1. Company Overview
  - 9.5.8.2. Product Type Portfolio
  - 9.5.8.3. Financial Overview
  - 9.5.8.4. Business Strategies and Development
- 9.5.9. Suneva Medical, Inc.
  - 9.5.9.1. Company Overview
  - 9.5.9.2. Product Type Portfolio
  - 9.5.9.3. Financial Overview
  - 9.5.9.4. Business Strategies and Development
- 9.5.10. Allergan
  - 9.5.10.1. Company Overview
  - 9.5.10.2. Product Type Portfolio
  - 9.5.10.3. Financial Overview
  - 9.5.10.4. Business Strategies and Development

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations